Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent

CompletedOBSERVATIONAL
Enrollment

829

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Prostate CancerOsteoporosis
Trial Locations (18)

Unknown

Research Site, Cheonan-si

Research Site, Gangneung-si

Research Site, Goyang-si

Research Site, Guri-si

Research Site, Gumi

Research Site, Gyeongju

Research Site, Masan-si

Research Site, Iksan-si

Research Site, Cheongju-si

Research Site, Chungju

Research Site, Daegu

Research Site, Daejeon

Research Site, Gwangju

Research Site, Incheon

Research Site, Jeju City

Research Site, Pusan

Research Site, Seoul

Research Site, Ulsan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY